XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Restatement of Previously Issued Financial Statements (Details) - Schedule of impact of the restatement on financial statements - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Dec. 31, 2020
Sep. 08, 2020
As Previously Reported [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Warrant Liabilities    
Total Liabilities $ 9,826,454 $ 9,826,454 9,925.075 9,801,183
Common Stock Subject to Possible Redemption 216,106,340 216,106,340 215,618,860 216,189,340
Class A Common Stock 193 193 198 192
Additional Paid-in Capital 5,083,766 5,083,766 5,571,241 5,000,863
Accumulated Deficit (84,739) (84,739) (572,217) (1,740)
Change in fair value of warrant liabilities  
Transaction costs allocable to warrant liabilities  
Net loss     $ (571,093)  
Basic and diluted net loss per share, Class A common stock (in Dollars per share) $ 0.00 $ 0.00 $ 0.00  
Basic and diluted net loss per share, Class B common stock (in Dollars per share) $ (0.01) $ (0.01) $ (0.07)  
Adjustments [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Warrant Liabilities     $ 27,837,928 13,592,898
Total Liabilities $ 14,457,629 $ 14,457,629 27,837,928 13,592,898
Common Stock Subject to Possible Redemption 13,893,660 13,893,660 14,381,140 13,810,660
Class A Common Stock (139) (139) (144) (138)
Additional Paid-in Capital (5,083,766) (5,083,766) (5,571,241) (5,000,863)
Accumulated Deficit (23,267,383) (23,267,383) (36,647,683) (22,400,652)
Change in fair value of warrant liabilities 866,731 866,731 14,245,031  
Transaction costs allocable to warrant liabilities $ 820,852 $ 820,852 820,852  
Net loss     $ (15,065,883)  
Basic and diluted net loss per share, Class A common stock (in Dollars per share) $ (0.06) $ (0.06) $ (0.51)  
Basic and diluted net loss per share, Class B common stock (in Dollars per share) $ (0.05) $ (0.05) $ (0.44)  
As Restated [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Warrant Liabilities     $ 27,837,928 13,592,898
Total Liabilities     37,763,003 23,394,081
Common Stock Subject to Possible Redemption     230,000,000 230,000,000
Class A Common Stock     54 54
Additional Paid-in Capital     0 0
Accumulated Deficit     (37,219,900) $ (22,402,392)
Change in fair value of warrant liabilities     14,245,031  
Transaction costs allocable to warrant liabilities     820,852  
Net loss     $ (15,636,976)  
Basic and diluted net loss per share, Class A common stock (in Dollars per share)     $ (0.51)  
Basic and diluted net loss per share, Class B common stock (in Dollars per share)     $ (0.51)